Stock Report

All about this stock under one free report Last Updated: 09-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

La Jolla Pharmaceutical Co (LJPC) Key Ratios

Stock Card factsheet share-fund-plan-icon

$6.22

$0.00 (0.00%)

As on 22-Aug-2022 09:30EDT

Market cap

info icon

$155 Mln

Revenue (TTM)

info icon

$46 Mln

P/E Ratio

info icon

47.8

P/B Ratio

info icon

0

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 1.13 -34.35 -33.79 37.84 224.61
EBIT 101.54 -24.32 4.35 27.92 16.49
Net Profit 122,800.00 -34.15 36.25 26.52 15.34
EPS 125,822.95 -30.04 440.86 26.35 15.10
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-21Dec-20
EBIT-Margin info -168.89-604.4130.0539.84-87.88
Net Margin info -462.66-7,720.458.54----
Return on equity info 396.80143.03---25.4054.72
Return on Capital info -831.93-594.21---25.9368.98
Return on Assets info -28.38-65.793.4222.67-38.56
Debt to Equity (x) info ----0.00-0.04-0.01

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
--
-25.93
68.98
-2,538.85
-321.41
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
--
-25.40
54.72
1,161.07
-321.41
Peer Median
-22.01
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

3.42

Higher than Peers by 15.97

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
3.42
22.67
-38.56
-69.24
-123.19
Peer Median
-12.55
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

30.05

Higher than Peers by 80.28

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
30.05
39.84
-87.88
-458.64
-1,910.96
Peer Median
-50.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

8.54

Higher than Peers by 65.32

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
8.54
25.96
-117.96
-462.66
-4,300.75
Peer Median
-56.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-33.79

Lower than Peers by 49.89

Year on year growth in net sales

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
-33.79
1.27
0.45
1.29
--
Peer Median
16.10
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

4.35

Lower than Peers by 8.33

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
4.35
202.71
72.22
44.98
-66.48
Peer Median
12.68
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

36.25

Higher than Peers by 27.86

Year on year growth in profit after tax

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
36.25
149.87
66.16
41.59
-73.75
Peer Median
8.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

440.86

Higher than Peers by 409.62

Year on year growth in earnings per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
440.86
1.40
0.66
0.46
-0.46
Peer Median
31.24
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-9.44

Lower than Peers by 11.58

Year on year growth in book value per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
-9.44
--
--
--
--
Peer Median
2.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
--
-0.04
-0.01
-0.52
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.00

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
0.00
-0.04
0.00
-0.05
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

4.02

Higher than Peers by 0.31

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
4.02
3.82
2.95
3.96
5.95
Peer Median
3.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

3.52

Lower than Peers by 0.15

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
3.52
3.46
2.47
3.87
5.88
Peer Median
3.67
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

1.40

Higher than Peers by 1.74

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
1.40
2.88
-2.92
-9.81
-26.31
Peer Median
-0.34
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

12.75

Lower than Peers by 10.57

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
12.75
15.83
17.46
12.84
13.73
Peer Median
23.32
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.40

Higher than Peers by 0.14

Sales / Average Total Assets

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
0.40
0.87
0.33
0.14
0.06
Peer Median
0.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
--
42.98
48.06
34.39
50.16
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
--
166.45
192.08
323.03
224.53
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
--
68.24
162.07
973.36
2,229.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
--
141.19
78.07
-615.95
-1,954.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

47.85

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
47.85
8.04
-2.66
-0.91
-1.18
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
--
-2.37
-1.19
-1.90
6.56
Peer Median
4.90
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

6.99

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
6.99
3.56
-3.32
-0.47
-0.34
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

155

Higher than Peers by 64

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
La Jolla Pharmaceutical Co (LJPC)
155
--
--
--
--
Peer Median
91
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...